Johnson & Johnson

05/07/2021 | Press release | Distributed by Public on 05/07/2021 07:13

Johnson & Johnson to Participate in Goldman Sachs 42nd Annual Global Healthcare Virtual Conference

New Brunswick, NJ (May 7, 2021) -- Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 42nd Annual Global Healthcare Virtual Conference on Tuesday, June 8th. Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 9:40 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48 hours after the live webcast.

###

  • Press Contacts:
    Christina Chan
    (732) 524-6297

    Investor Contacts:
    Christopher DelOrefice
    (732) 524-2955

    Jennifer McIntyre
    (732) 524-3922